• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PROMUS PREMIER; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number 9553
Device Problems Failure to Advance (2524); Wrong Label (4073)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/03/2023
Event Type  malfunction  
Manufacturer Narrative
E1- initial reporter address 1: (b)(6).
 
Event Description
It was reported that a labelling issue occurred.The patient underwent percutaneous coronary intervention (pci) of the 82% stenosed target lesion located in the severely tortuous and severely calcified left circumflex (lcx) artery.A 32 x 3.00mm promus premier drug-eluting stent was advanced for treatment but failed to cross the lesion.It was also noted that the label on the internal packaging indicated a different batch number than the label on the external packaging.No damage to the package prior to opening was noted.The procedure was completed with another of the same device.There were no patient complications reported and the patient status was stable.
 
Event Description
It was reported that a labelling issue occurred.The patient underwent percutaneous coronary intervention (pci) of the 82% stenosed target lesion located in the severely tortuous and severely calcified left circumflex (lcx) artery.A 32 x 3.00mm promus premier drug-eluting stent was advanced for treatment but failed to cross the lesion.It was also noted that the label on the internal packaging indicated a different batch number than the label on the external packaging.No damage to the package prior to opening was noted.The procedure was completed with another of the same device.There were no patient complications reported and the patient status was stable.It was further reported that the batch number of the label was found to be inconsistent with the batch number of the device itself when the complaint was reported.The device itself was not marked with the size.
 
Manufacturer Narrative
E1: initial reporter address 1: (b)(6).
 
Manufacturer Narrative
(b)(6).Device evaluated by mfr.: promus premier ous mr 32 x 3.00mm stent delivery system catheter was returned for analysis.A visual examination of the crimped stent identified no damage.The stent was securely crimped between both markerbands.The balloon cones were reviewed, and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.A visual and microscopic examination of the bumper tip identified no damage.A visual and tactile examination of the hypotube shaft found a kink 4.5cm distal to the distal end of the strain relief.A visual and tactile examination of the outer and mid-shaft section and a visual examination of the inner lumen found no issues along the shaft polymer extrusion.No other issues were identified during analysis.
 
Event Description
It was reported that a labelling issue occurred.The patient underwent percutaneous coronary intervention (pci) of the 82% stenosed target lesion located in the severely tortuous and severely calcified left circumflex (lcx) artery.A 32 x 3.00mm promus premier drug-eluting stent was advanced for treatment but failed to cross the lesion.It was also noted that the label on the internal packaging indicated a different batch number than the label on the external packaging.No damage to the package prior to opening was noted.The procedure was completed with another of the same device.There were no patient complications reported and the patient status was stable.It was further reported that the batch number of the label was found to be inconsistent with the batch number of the device itself when the complaint was reported.The device itself was not marked with the size.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS PREMIER
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jeff wallner
4100 hamline ave n
arden hills, MN 55112
6515811560
MDR Report Key16778823
MDR Text Key314023886
Report Number2124215-2023-15719
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 06/15/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/20/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number9553
Device Catalogue Number9553
Device Lot Number0030203944
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/26/2023
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/14/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age82 YR
Patient SexMale
Patient Weight60 KG
-
-